本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cellectis S.A.

1.18
-0.0800-6.35%
盘后:1.180.00000.00%19:30 EDT
成交量:12.26万
成交额:14.58万
市值:1.19亿
市盈率:-1.82
高:1.28
开:1.25
低:1.14
收:1.26
52周最高:5.48
52周最低:1.14
股本:1.01亿
流通股本:7,660.01万
量比:1.71
换手率:0.16%
股息:- -
股息率:- -
每股收益(TTM):-0.6479
每股收益(LYR):-0.6740
净资产收益率:-94.54%
总资产收益率:-11.67%
市净率:2.90
市盈率(LYR):-1.75

数据加载中...

公司资料

公司名字:
Cellectis S.A.
交易所:
NASDAQ
成立时间:
1999
员工人数:
227
公司地址:
8, rue de la Croix Jarry,Paris,Ile-de-France,France
邮编:
75013
传真:
- -
简介:
Cellectis S.A.于2000年1月4日成立。该公司是一家处于临床阶段的生物技术公司,利用他们的核心专有技术开发基于基因编辑的产品,拥有一系列同种异体嵌合抗原受体T细胞,即免疫肿瘤学领域的候选产品和基因编辑造血干细胞和祖细胞,即HSPC,其他治疗适应症的候选产品。

董事

名称
职位
Andre Choulika
Director, Chief Executive Officer and Co-Founder
David Sourdive
Director, Deputy Chief Executive Officer, Executive Vice President, CMC and Manufacturing
Jean Pierre Garnier
Chairman of the Board and Director
André Muller
Independent Director
Cécile Chartier
Independent Director
Donald A. Bergstrom
Independent Director
Laurent Arthaud
Independent Director
Marc Dunoyer
Independent Director
Rainer Boehm
Independent Director
Tyrell Rivers
Independent Director

股东

名称
职位
Andre Choulika
Director, Chief Executive Officer and Co-Founder
David Sourdive
Director, Deputy Chief Executive Officer, Executive Vice President, CMC and Manufacturing
Arthur Stril
Chief Business Officer and Chief Financial Officer
Steven Doares
Senior Vice President of US Manufacturing
Adrian Kilcoyne
Chief Medical Officer
Kyung Nam Wortman
Chief Human Resources Officer
Marie Bleuenn Terrier
General Counsel
Philippe Duchateau
Chief Scientific Officer
Stephan Reynier
Chief Regulatory & Pharmaceutical Compliance Officer